to
This webinar aims to review the highly variable clinical course of Autosomal Dominant Polycystic Kidney Disease (ADPKD), including the spectrum of pediatric and adolescent ADPKD presentation.
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Calendar of Events
S SunM MonT TueW WedT ThuF FriS Sat0 events,0 events,2 events,
to
This webinar aims to review the highly variable clinical course of Autosomal Dominant Polycystic Kidney Disease (ADPKD), including the spectrum of pediatric and adolescent ADPKD presentation.
0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,1 event,to
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD).
0 events,0 events,0 events,0 events,2 events,to
In this cutting-edge webinar, we will discuss the most current data on biomarkers in ADPKD, focusing on those that are most validated in the literature.
to
In this cutting-edge webinar, we will discuss the most current data on biomarkers in ADPKD, focusing on those that are most validated in the literature.
0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,2 events,to
In this webinar, we will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
to
In this webinar, we will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
